Czech National Bank Raises Stock Position in Cardinal Health, Inc. $CAH

Posted by Brian Himes on Aug 8th, 2026

Czech National Bank grew its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 4.0% during the 2nd quarter, Holdings Channel reports. The firm owned 66,664 shares of the company’s stock after buying an additional 2,577 shares during the period. Czech National Bank’s holdings in Cardinal Health were worth $15,837,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CAH. University of Texas Texas AM Investment Management Co. purchased a new position in shares of Cardinal Health in the 4th quarter worth $26,000. Bank of Jackson Hole Trust bought a new stake in Cardinal Health during the fourth quarter valued at $27,000. Jones Financial Companies Lllp boosted its position in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Palladiem LLC bought a new position in Cardinal Health in the 4th quarter worth approximately $28,000. Finally, Indiana Trust & Investment Management Co bought a new stake in Cardinal Health during the first quarter worth approximately $29,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.5%

NYSE:CAH opened at $236.57 on Friday. The firm has a market capitalization of $55.41 billion, a price-to-earnings ratio of 36.17, a PEG ratio of 1.16 and a beta of 0.49. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $244.87. The business’s fifty day moving average price is $226.64 and its 200 day moving average price is $216.23.

Analyst Upgrades and Downgrades

Several brokerages have commented on CAH. William Blair started coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. cut their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. UBS Group upped their target price on Cardinal Health from $260.00 to $274.00 and gave the company a “buy” rating in a report on Monday, July 20th. Bank of America raised their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. Finally, Citigroup boosted their price target on shares of Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a report on Friday, July 24th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $251.73.

Get Our Latest Analysis on Cardinal Health

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Czech National Bank Raises Stock Position in Cardinal Health, Inc. $CAH

Cardinal Health Trading Down 0.5%

Analyst Upgrades and Downgrades

Cardinal Health Profile

See Also

You might be interested in: